» Articles » PMID: 28932076

Ophthalmic Manifestations in Patients with Inflammatory Bowel Disease: A Review

Overview
Specialty Gastroenterology
Date 2017 Sep 22
PMID 28932076
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical manifestations of inflammatory bowel disease (IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in PubMed, was performed. Episcleritis, the most common ocular extraintestinal manifestation (EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn's disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly non-specific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.

Citing Articles

Unraveling the causal association between inflammatory bowel diseases and uveitis through mendelian randomization analysis.

Zhong M, An H, Gan H Sci Rep. 2025; 15(1):5686.

PMID: 39956872 PMC: 11830775. DOI: 10.1038/s41598-025-90462-w.


Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies.

Richardson H, Yoon G, Moussa G, Kumar A, Harvey P Biomedicines. 2025; 12(12.

PMID: 39767762 PMC: 11673599. DOI: 10.3390/biomedicines12122856.


Crohn's disease-associated keratopathy: A case report.

Kim J, Won Y, Chung T, Lim D Am J Ophthalmol Case Rep. 2024; 36:102186.

PMID: 39435154 PMC: 11492095. DOI: 10.1016/j.ajoc.2024.102186.


A Comprehensive Review of Ocular Manifestations in Systemic Diseases.

Kumar Jr M, Kotak P, Acharya S, Nelakuditi M, Parepalli A Cureus. 2024; 16(7):e65693.

PMID: 39211636 PMC: 11358114. DOI: 10.7759/cureus.65693.


Concomitant ulcerative colitis and Usher syndrome in a Pakistani patient: A novel case report.

Siddiqui F, Ashkar A, Aamir S SAGE Open Med Case Rep. 2024; 12:2050313X241272501.

PMID: 39157038 PMC: 11329895. DOI: 10.1177/2050313X241272501.


References
1.
Jabs D, Rosenbaum J, Foster C, Holland G, Jaffe G, Louie J . Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000; 130(4):492-513. DOI: 10.1016/s0002-9394(00)00659-0. View

2.
Christodoulou D, Katsanos K, Kitsanou M, Stergiopoulou C, Hatzis J, Tsianos E . Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis. 2003; 34(11):781-6. DOI: 10.1016/s1590-8658(02)80071-8. View

3.
Harbord M, Annese V, Vavricka S, Allez M, Barreiro-de Acosta M, Boberg K . The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2015; 10(3):239-54. PMC: 4957476. DOI: 10.1093/ecco-jcc/jjv213. View

4.
Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali G . Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015; 34(5):387-94. DOI: 10.1007/s12664-015-0598-8. View

5.
Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G . Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2006; 11(46):7227-36. PMC: 4725142. DOI: 10.3748/wjg.v11.i46.7227. View